Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect [PMID: 9149058] Laboratory literature summary: Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized
Lyophilized at -20C: stable 24+ months
BPC-157 CAS #: 137525-51-0 Quantity BPC-157 Order now, ships today One-time Adjust quantity in your cart
BPC-157 is notably stable in the gastric environment in preclinical models reportedly remaining intact in human gastric juice for extended periods which is one reason it has been studied so extensively in gut-related research
This means it doesn't elevate IGF-1 levels or negatively impact glucose tolerance, making its safety profile distinct
What is an IV infusion
/i.s3.glbimg.com/v1/AUTH_da025474c0c44edd99332dddb09cabe8/internal_photos/bs/2023/N/u/ri3uo2StSmDx0Jkt0hBQ/arte-1-.png)
US$ 26.73
US$ 29.28
US$ 27.02
US$ 27.99
,aspect=ignore)
US$ 21.08
